
Investment and innovation in drug research and development (RD) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug RD for prevalent chronic diseases.
Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Limba Engleză ● Format EPUB ● Pagini 112 ● ISBN 9780309092395 ● Editor Amanda Wagner Gee & Andrew March ● Editura National Academies Press ● Publicat 2021 ● Descărcabil 3 ori ● Valută EUR ● ID 8273859 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM